Journal of Comparative Effectiveness Research | Becaris Publishing

background gradient

Submit an article For Authors Sign up for Alerts Visit The Evidence Base

Letter to the Editor: Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema
- Irmgard Andresen,
- Natalie Khutoryansky,
- Sarah L Feeny, and
- Alissa Dangel
19 Oct 2026
Response to Letter to the Editor regarding “Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema”
- Yinglei Li,
- Simona Gavata-Steiger,
- Chiara Nenci,
- Nicolas Scheuer,
- Sarah Walsh,
- Anja Haltner, and
- Imtiaz A Samjoo
19 Oct 2026
Methodological considerations for indirect treatment comparisons of HIV incidence for long-acting injectable pre-exposure prophylaxis
- Tristan Curteis,
- Aidan N Franklin,
- Rebecca K Judge,
- Anna Zolotor,
- James Jarrett,
- Christoph C Carter,
- Ramin Ebrahimi, and
- Dylan Mezzio
15 Oct 2026
Real-world cost-effectiveness of sequential therapy of in-class transition to ixazomib versus daratumumab for transplant-ineligible newly diagnosed multiple myeloma in China
- Genyong Zuo,
- Aijun Liu,
- Zunmin Zhu,
- Li Bao,
- Lihong Liu,
- Yongbo Gao,
- Wendong Chen,
- Rong Fu, and
- Wenming Chen
13 Oct 2026

background gradient

Open Access

Submit an Article